Harnessing mucosal immunity for protective vaccines - Nature
Harnessing mucosal immunity for protective vaccines Nature
Harnessing mucosal immunity for protective vaccines Nature
Vaccine symposium airs multiple ideas for accelerating preventive immunology Stanford Medicine
Editorial: Vaccines and molecular therapeutics for tuberculosis Frontiers
COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes Science | AAAS
Cancer vaccines as enablers of immunotherapy Nature
One vaccine may provide broad protection against many respiratory infections and allergens Stanford Medicine
Infection, vaccination and risk of dementia: a proposed immunological model Frontiers
T cell immunity in vaccination and disease Nature
Vaccination in the post-COVID era: lessons to be learned in Latin America Frontiers
Sex differences in immune responses to viruses, bacteria and vaccines Nature
Next-generation vaccines against bacterial pathogens: mRNA and beyond Frontiers
‘Universal vaccine’ protects mice against multiple pathogens Nature
Development of human mycoplasma vaccines: navigating the IL-17A paradox Frontiers
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms Nature
Editorial: Mucosal immunity after vaccination Frontiers
The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuates the adaptive immune response Frontiers
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC Nature
mRNA-based SARS-CoV-2 vaccines: The intracellular aggregation of encoded spike monomers and their subunits as a cause of cardiac side effects Frontiers
Eliciting antitumor immunity via therapeutic cancer vaccines Nature
Advances in molecular adjuvants for nucleic acid vaccines Frontiers
Targets of protective immunity and opportunities in hepatitis C virus vaccine development Nature
Opinion | I Grew Up Unvaccinated. Now I’m an Immunologist. The New York Times
Melioidosis vaccines: recent advances and future directions Frontiers
T cells responses after vaccination: a regulatory perspective Frontiers
Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies Frontiers
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice Nature
Upcoming seminar: Professors Hatherill & Nemes- TB Vaccines & Immunology Seminar, 19 March 2026 (13:00–14:00) University of Cape Town
BSI launch guide to vaccinations during pregnancy British Society for Immunology
A review of the efficacy of clinical tuberculosis vaccine candidates in mouse models Frontiers
A guide to vaccinology: from basic principles to new developments Nature
The recent advances in vaccine adjuvants Frontiers
Artificial intelligence in vaccine research and development: an umbrella review Frontiers
British Society for Immunology release new guide to vaccinations during pregnancy British Society for Immunology
Immune responses to human papillomavirus infection and vaccination Frontiers
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations Frontiers
New Horizons for Immunology and Vaccine Research at Cincinnati Children’s Research Horizons
NIH’s key vaccine center slammed by contract cuts Science | AAAS
Induction of Regulatory T Cells After Virus Infection and Vaccination - Kakh - Immunology Wiley Online Library
Blood test can predict how long vaccine immunity will last, Stanford Medicine-led study shows Stanford Medicine
Vaccines and Immunology: Learning the Pandemic’s Lessons Duke University School of Medicine